Search results
Newfound autoimmune syndrome tied to COVID-19 can trigger deadly lung scarring
Live Science via Yahoo News· 6 days agoAn illustration of Y shaped antibodies in front of a coronavirus particle, blurred in the...
Evolving With the Virus: Repeat COVID-19 Shots Neutralizing Beyond the Expected
SciTechDaily· 1 day agoThe response to an updated vaccine is influenced by previous vaccinations but also produces broadly...
Repeat COVID Vaccination Could Shield Against Wide Range of Viruses
WFMZ Eastern Pennsylvania and Western New Jersey· 3 days agoPowerful COVID vaccines could be setting people’s immune systems up to successfully fight off not...
Keeping Up With COVID Vaccines Arms The Immune System Against Future Variants And Viruses
IFLScience· 4 days agoResearchers led by a team at Washington University School of Medicine found that the antibodies...
With new variants, do experts predict a summer COVID-19 surge?
Deseret News via Yahoo News· 4 days agoMichelle Budge, Deseret News COVID-19 levels have been lower than usual, but a new set of variants...
InnovationRx: Under 30 Alum Raises $35 Million For Virtual Addiction Treatment
Forbes· 2 days agoInnovationRx is your weekly digest of healthcare news. Stephanie Papes Strong took the opposite...
Doing What’s Right
KGTV San Diego· 4 days agoKeep track of the way people are spending your tax dollars and treating your community.
mRNA Vaccines vs. the Pandemic
The North Coast Journal· 1 day agoAbout 13 billion doses of mRNA vaccines against the virus have now been given in 184 countries, including 600 million in the U.S. alone. While some 7...
Outbreak of Natural Severe Fever with Thrombocytopenia Syndrome Virus Infection in Farmed Minks,...
Centers for Disease Control and Prevention· 7 hours agoNatural Severe Fever with Thrombocytopenia Syndrome Virus Infection in Farmed Minks, China
NanoViricides Bolsters Partnership Efforts - Engages Aagami Inc.
The Kansas City Star· 20 hours agoSHELTON, CT / ACCESSWIRE / May 23, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical-stage global leader in broad-spectrum antiviral nanomedicines, reports that it ...